Amerigo Capital
Founded in 2015, Amerigo seeks to make control investments in lower middle market companies. Based in Irvine, Calif., the firm targets companies with EBITDA from $2 million to $20 million across a variety of industries, including biotech, pharmaceutical and healthcare IT.
